Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-25

FDA Approved: PEMETREXED — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals' original application for pemetrexed disodium, a generic version of pemetrexed for cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed disodium (Pemetrexed disodium)

Snippet

ORIG AP for PEMETREXED (PEMETREXED DISODIUM)